Azurin p28 peptide
Tocris Bioscience | Catalog # 7662
Increases p53 levels; binds p53 and inhibits COP1-mediated ubiquitination of p53
Discontinued Product
7662 has been discontinued.
View all p53 products.
Key Product Details
Description
Increases p53 levels; binds p53 and inhibits COP1-mediated ubiquitination of p53
Product Description
Azurin p28 peptide is a 28 amino acid fragment of azurin (amino acids 50-77). The peptide is preferentially taken up by human breast cancer cell lines via caveolin-mediated endocytosis. Azurin p28 peptide binds wild-type and mutant p53 protein and inhibits E3 ligase COP1-mediated ubiquitination of p53 by >80%, resulting in decreased proteasomal degradation of p53. It induces cell cycle arrest in the G2/M phase leading to apoptosis. Azurin p28 peptide exhibits antiproliferative effects in human breast cancer cells in vitro and in vivo.
Product Specifications for Azurin p28 peptide
Molecular Weight
2914.20
Formula
C122H197N31O47S2
Storage
Store at -20°C
Purity
≥95% (HPLC)
CAS Number
897026-25-4
PubChem ID
53363312
InChI Key
RFGPECAMUVWTJN-AWHPYGDNSA-N
SMILES
O=C(N[C@@H](CO)C(N[C@@H]([C@H](O)C)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCSC)C(N[C@@H](CCC(N)=O)C(NCC(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(O)=O)C(NCC(N[C@@H](CCSC)C(N[C@@H](C)C(N[C@@H](CO)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CC(O)=O)C(N[C@@H](CCCCN)C(N[C@@H](CC(O)=O)C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N2[C@@H](CCC2)C(N[C@@H](CC(O)=O)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Loading...
Solubility
| Solubility | Soluble to 2mg/ml in 0.01M PBS |
Calculators
Background References
References are publications that support the biological activity of the product.
- Yamada p28, a first in class peptide inhibitor of cop1 binding to p53. Br.J.Cancer 2013 PMID: 23736031
- Yamada A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Mol.Cancer Ther. 2009 PMID: 19808975
- Yaghoubi p28 bacterial peptide, as an anticancer agent. Front.Oncol. 2020 PMID: 32850408
Product Documents for Azurin p28 peptide
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Product Specific Notices for Azurin p28 peptide
For research use only
Customer Reviews for Azurin p28 peptide
There are currently no reviews for this product. Be the first to review Azurin p28 peptide and earn rewards!
Have you used Azurin p28 peptide?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Loading...